-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol2/Schiff.pdf
January 01, 2005 - in an
outpatient clinic
Blood glucoses meeting criteria for DM with no diagnosis
of diabetes in … for abnormal results, such as elevated
thyroid stimulating hormone [TSH], unaddressed by thyroxin therapy … Case 4
A 50-year-old woman with a past history diabetes and alcohol and IV drug
abuse, presents with … ultrasound was initially interpreted as being “positive,” illustrates the pitfalls of
taking irreversible therapeutic … Risk management issues in glaucoma
diagnosis and treatment.
-
www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/tools-and-materials/ehr-reports.pdf
March 01, 2016 - Query 1 may list the patient identifiers for
all patients with a given chronic disease such
as diabetes … Treatment
Producing Accurate Clinical Quality Reports for Population Health | Qualis Health | … 10 of 21
Reporting for Population Health
The Entire Panel
People Over 18 Years Old
People with Diabetes … If the clinical condition is a chronic illness, such as
diabetes, the presence of an ICD code on the … define
a target population (such as pregnancy, smoking
status, or being followed for anticoagulation therapy
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-family-engagement/pfeprimarycare/teambased-1.pdf
May 02, 2016 - is low:
Up to 80 percent of nurse and physician work output
is waste, not from ordering tests or treatments … patient and the
CTC and increases patient engagement with care
planning and adherence to recommended therapies … provider to actively
engage the patient in decisionmaking, identification
of challenges to recommended therapies … ■ Effective use of the extended care team: An
extended care team, including pharmacists, diabetes
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/final-reports/ssi/ssiapu.pptx
September 18, 2011 - order #8
ADMIT_SRC
ICU_ADMIT
INPAT_SURG
OUTPAT_SURG
AGE
BMI
CA_HX
CH_KIDNEY_DX
CH_LUNG_DX
COPD_HX
DIABETES … Indicative of need for hospitalization for post operative wound treatment. … preoperative risk factor, this finding was indicative of the need for hospitalization for post operative wound treatment
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2015Q4_Severity.PDF
October 31, 2017 - 3,531 0.08%
405: Other procedures for endocrine, nutritional & metabolic disorders 986 0.02%
420: Diabetes … dependence, left against medical advice 6,903 0.16%
772: Alcohol & drug dependence w rehab or rehab/detox therapy … 0.66%
776: Other drug abuse & dependence 3,905 0.09%
791: O.R. procedure for other complications of treatment … reactions 3,428 0.08%
812: Poisoning of medicinal agents 25,782 0.60%
813: Other complications of treatment
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2016_Severity.PDF
January 01, 2016 - 12,586 0.07%
405: Other procedures for endocrine, nutritional & metabolic disorders 4,155 0.02%
420: Diabetes … dependence, left against medical advice 28,852 0.17%
772: Alcohol & drug dependence w rehab or rehab/detox therapy … 0.68%
776: Other drug abuse & dependence 16,660 0.10%
791: O.R. procedure for other complications of treatment … reactions 14,309 0.08%
812: Poisoning of medicinal agents 100,501 0.58%
813: Other complications of treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/pregnancy_hi_impact.pdf
January 01, 2012 - new (and new uses of existing) pharmaceuticals, medical devices,
diagnostic tests and procedures, therapeutic … purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices,
procedures, treatments … , screening and diagnostics, therapeutics, surgery, programs, and care delivery
innovations that address … CDB-2914 (ulipristal acetate) for treatment of uterine fibroids
2. … and the treatment is
potentially more expensive than the current treatment available as well.”
41
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
January 01, 2023 - Intervention C Intervention C, Dose Received (Mean) Intervention D Intervention D, Dose Received (Mean) Treatment … Previous treatment with weak opioid: 42 vs. 38
Previous treatment with strong opioid: 19 vs. 11 96 71 … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-F1-4.xlsx
January 01, 2022 - Intervention C Intervention C, Dose Received (Mean) Intervention D Intervention D, Dose Received (Mean) Treatment … Previous treatment with weak opioid: 42 vs. 38
Previous treatment with strong opioid: 19 vs. 11 96 71 … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-tables-F1-4.xlsx
January 01, 2022 - Intervention C Intervention C, Dose Received (Mean) Intervention D Intervention D, Dose Received (Mean) Treatment … Previous treatment with weak opioid: 42 vs. 38
Previous treatment with strong opioid: 19 vs. 11 96 71 … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-1-app-F.xlsx
January 01, 2023 - Intervention C Intervention C, Dose Received (Mean) Intervention D Intervention D, Dose Received (Mean) Treatment … Previous treatment with weak opioid: 42 vs. 38
Previous treatment with strong opioid: 19 vs. 11 96 71 … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments … NA NA NA NA NA NA NR NR NR NR NR NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA Unclear Unclear NA NA Treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/mcda_webinar_transcript2.pdf
August 27, 2012 - Suppose this example if you want to get the best
treatment we have to choose for best treatments we … The pattern of choices
reveals the implicit decision weights of patients attached
to a therapeutic … It might require better diabetes education if we
believe patients don’t understand the long-term risks … Vasomotor symptoms
are related to hormone replacement therapy. … These caregivers often are people who are
making or helping to make therapeutic decisions.
-
psnet.ahrq.gov/perspective/health-care-data-science-quality-improvement-and-patient-safety
October 01, 2016 - characterize everyone who's eligible for care, those who have received specific diagnoses, tests, and treatment … For instance, major responsibility for following up women with gestational diabetes who have not had … We already mentioned finding women who require postpartum assessment of diabetes status. … to identify patients who are at risk for problems with opioid dependence or complications of opioid therapy
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/mgmt-hnhc-patients-protocol.pdf
November 07, 2019 - health care providers and social support
systems, which, in turn, could increase adherence to their treatment … as usual, or no comparator
intervention
KQ 3: Any intervention or treatment as usual
KQ 3: No … limiting them to specific conditions or combinations
of conditions (e.g., cardiovascular disease, diabetes … DSM-III-R
diagnoses and treatment needs. Gen Hosp Psychiatry. 1990;12(6):355‐62. … Comorbidity"[Mesh]) OR "multimorbidity"
[MeSH] Sort by: Best Match
100740
#3 Search ((((((((((((((((((("Diabetes
-
psnet.ahrq.gov/web-mm/medical-devices-wild
March 27, 2024 - Case A 75-year-old man with a history of congestive heart failure (CHF), coronary artery disease, diabetes … After a short period of treatment, his swelling improved and he was able to ambulate on the hospital
-
psnet.ahrq.gov/node/49568/psn-pdf
September 01, 2008 - The
treatment—frenotomy—is a simple, safe, and effective surgical procedure. … Infants who are not breastfed also have a higher risk of developing obesity and
diabetes.
-
psnet.ahrq.gov/web-mm/wrong-channel
February 01, 2003 - The Case A 28-year-old woman in labor began receiving treatment with magnesium sulfate for preeclampsia … WebM&M Cases
Inpatient Stroke Management in an Adolescent with Type 1 Diabetes
-
psnet.ahrq.gov/web-mm/mistaken-dose-naloxone
March 21, 2009 - after chemotherapy, but his abdominal and bony pain due to metastases was well controlled with opioid therapy … opioid-related harm, the 2016 CDC guidelines provided recommendations on the use of opioids for the treatment … Erika Cutler, PharmD
Pharmacy and Therapeutics Coordinator
University of California, Davis
Assistant … counseling and health education: a survey of their knowledge and level of involvement in relation to type 2 diabetes
-
psnet.ahrq.gov/node/865778/psn-pdf
May 29, 2024 - His past medical history included hypertension treated with
lisinopril, diabetes treated with metformin … guidewire necessitated
recovery through emergency operative exploration, which delayed his hemodialysis treatment
-
psnet.ahrq.gov/web-mm/safeguarding-diagnostic-testing-point-care
September 30, 2011 - point-of-care testing at home, such as international normalized ratio for monitoring warfarin anticoagulation therapy … or self-testing of blood glucose for diabetes, education and guidance should be provided to the patient … Persistent human chorionic gonadotropin after methotrexate treatment and an emergency surgical procedure